Phibro Animal Health Corporation PAHC
34.45
0.52
1.53%
as of 25 Sep
- Market cap
- $1.4B
- P/E
- 14.0×
Follow PAHC
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
23.79% | 31.80% | 30.34% | 29.72% | |
| 5.77% | 6.84% | 6.90% | 6.97% | ||
ROIC |
9.29% | 10.67% | 11.03% | 11.72% | |
Return on Tangible Assets |
7.37% | 9.85% | 9.80% | 10.09% | |
Average Days of Receivables |
56.82 | 53.81 | 53.91 | 57.41 | |
Free Cash Flow per Share |
0.85 | 1.17 | 0.31 | 0.24 | |
Free Cash Flow |
34.29 | 47.29 | 12.77 | 9.87 | |
Capital Expenditures |
(42.52) | (45.79) | (53.36) | (59.09) | |
Piotroski F-Score |
5.00 | 7.00 | 7.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
6.74% | 8.18% | 5.63% | 5.74% | |
Accounts Receivable Turnover |
7.39 | 7.18 | 7.16 | 6.50 | |
Accounts Payable Turnover |
8.87 | 8.57 | 7.75 | 7.57 | |
Inventory Turnover |
2.59 | 2.11 | 2.05 | 2.05 | |
Average Days of Payables |
49.48 | 48.78 | 46.76 | 46.21 | |
Days of Inventory on Hand |
178.73 | 189.34 | 194.67 | 194.15 | |
Tax Rate |
(0.28) | (0.27) | (0.26) | (0.27) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.88% | 20.36% | 20.54% | 20.96% | |
Share Based Compensation of Revenue |
0.06% | 0.08% | 0.09% | 0.11% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.13 | 1.01 | 0.69 | 0.69 | |
Depreciation/Fixed assets |
0.15 | 0.15 | 0.15 | 0.15 | |
Capex/Depreciation |
(0.82) | (0.86) | (1.01) | (1.10) | |
Revenue per Share |
34.53 | 36.13 | 36.99 | 37.44 | |
Operating CF per Share |
1.89 | 2.30 | 1.63 | 1.70 | |
Capex per Share |
(1.05) | (1.13) | (1.32) | (1.46) | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.04 | |
Net Profit Margin |
4.85% | 6.29% | 6.35% | 6.57% |
Columns are period end dates